[New post] Roche’s (RHHBY) Tecentriq Gets FDA Nod for Another Indication (Revised)

Editorial Team posted: "Roche (RHHBY) immuno-oncology drug Tecentriq gets FDA approval for yet another indication of lung cancer. Find out more at https://ift.tt/2Zb6sN3 via Entrepreneur.com" New post on Technology & Business News Roche's (RHHBY) Tecentriq Gets FDA Nod for Another Indication (Revised) by Editorial Team Roche (RHHBY) immuno-oncology drug Tecentriq gets FDA approval for yet another indication of lung cancer. Find out more at https://ift.tt/2Zb6sN3 via Entrepreneur.com Read more of this post This free site is ad-supported. Learn more ​ Editorial Team | October 21, 2021 at 4:10 am | Tags: Entrepreneur | Categories: Business | URL: https://wp.me/pcbvJV-aQS Like Unsubscribe to no longer receive posts from Technology & Business News. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://technologyandbusinessnews.wordpress.com/2021/10/21/roches-rhhby-tecentriq-gets-fda-nod-for-another-indication-revised/ Thanks for flying with WordPress.com